[{"address1": "150 West 4th Ave", "city": "Vancouver", "state": "BC", "zip": "V5Y 1G6", "country": "Canada", "phone": "604 559 9005", "website": "https://www.abcellera.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 596, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl L.G. Hansen Ph.D.", "age": 49, "title": "CEO, President & Chairperson", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 746836, "exercisedValue": 210706, "unexercisedValue": 2408685}, {"maxAge": 1, "name": "Mr. Andrew  Booth M.B.A.", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 671720, "exercisedValue": 0, "unexercisedValue": 12299500}, {"maxAge": 1, "name": "Dr. Veronique  Lecault Ph.D.", "age": 39, "title": "CTO & Director", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 667706, "exercisedValue": 230210, "unexercisedValue": 1260000}, {"maxAge": 1, "name": "Mr. Tryn T. Stimart Esq., J.D., M.Sc.", "age": 54, "title": "Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 685080, "exercisedValue": 0, "unexercisedValue": 3502170}, {"maxAge": 1, "name": "Marcie  Thiessen CPA, CGA", "title": "Senior Director of Finance & Accounting", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tiffany  Chiu B.Sc., Ph.D.", "title": "Vice President of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Graham  Craig M.Sc.", "title": "Director of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Murray  McCutcheon Ph.D.", "title": "Senior Vice President of Partnering", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil  Aubuchon B.A., M.B.A.", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 684813, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam  Clarke M.A.I.C.D., Ph.D.", "title": "Senior Vice President of Discovery", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.47, "open": 4.23, "dayLow": 4.185, "dayHigh": 4.445, "regularMarketPreviousClose": 4.47, "regularMarketOpen": 4.23, "regularMarketDayLow": 4.185, "regularMarketDayHigh": 4.445, "payoutRatio": 0.0, "beta": 0.617, "forwardPE": -6.424242, "volume": 6394383, "regularMarketVolume": 6394383, "averageVolume": 6236064, "averageVolume10days": 6690570, "averageDailyVolume10Day": 6690570, "bid": 4.21, "ask": 4.26, "bidSize": 31, "askSize": 21, "marketCap": 1334226176, "fiftyTwoWeekLow": 1.891, "fiftyTwoWeekHigh": 5.82, "priceToSalesTrailing12Months": 57.723724, "fiftyDayAverage": 3.5144, "twoHundredDayAverage": 2.909825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 728155968, "profitMargins": 0.0, "floatShares": 202402451, "sharesOutstanding": 298484992, "sharesShort": 35716688, "sharesShortPriorMonth": 26518430, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.1197, "heldPercentInsiders": 0.22968, "heldPercentInstitutions": 0.492, "shortRatio": 5.2, "shortPercentOfFloat": 0.15529999, "impliedSharesOutstanding": 314676000, "bookValue": 3.427, "priceToBook": 1.2372336, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -167868000, "trailingEps": -0.56, "forwardEps": -0.66, "enterpriseToRevenue": 31.503, "enterpriseToEbitda": -3.15, "52WeekChange": 0.5362319, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 4.24, "targetHighPrice": 17.0, "targetLowPrice": 5.0, "targetMeanPrice": 9.14286, "targetMedianPrice": 9.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 605265984, "totalCashPerShare": 2.028, "ebitda": -231196000, "totalDebt": 67847000, "quickRatio": 8.863, "currentRatio": 10.146, "totalRevenue": 23114000, "debtToEquity": 6.632, "revenuePerShare": 0.078, "returnOnAssets": -0.12936, "returnOnEquity": -0.15595001, "grossProfits": -147354000, "freeCashflow": -189059504, "operatingCashflow": -78402000, "revenueGrowth": -0.575, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -14.79575, "financialCurrency": "USD", "symbol": "ABCL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": 0.2217068, "postMarketPrice": 4.2494, "postMarketChange": 0.009400368, "regularMarketChange": -0.23, "regularMarketDayRange": "4.185 - 4.445", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 6236064, "fiftyTwoWeekLowChange": 2.3489997, "fiftyTwoWeekLowChangePercent": 1.2421998, "fiftyTwoWeekRange": "1.891 - 5.82", "fiftyTwoWeekHighChange": -1.5800004, "fiftyTwoWeekHighChangePercent": -0.27147773, "fiftyTwoWeekChangePercent": 53.623188, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754596800, "earningsCallTimestampStart": 1754600400, "earningsCallTimestampEnd": 1754600400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.56, "epsForward": -0.66, "epsCurrentYear": -0.65833, "priceEpsCurrentYear": -6.4405384, "fiftyDayAverageChange": 0.72559977, "fiftyDayAverageChangePercent": 0.20646477, "twoHundredDayAverageChange": 1.3301747, "twoHundredDayAverageChangePercent": 0.4571322, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-12-11", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607697000000, "corporateActions": [], "postMarketTime": 1754092366, "regularMarketTime": 1754078402, "regularMarketChangePercent": -5.14541, "regularMarketPrice": 4.24, "exchange": "NMS", "messageBoardId": "finmb_280568380", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "AbCellera Biologics Inc.", "longName": "AbCellera Biologics Inc.", "displayName": "AbCellera Biologics", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]